Brief: Laurus Labs Approves 833 Mln Rupees Investment In KRKA Pharma
06/03/2025 12:17
March 6 (Reuters) - Laurus Labs Ltd LAUL.NS: APPROVES 833 MILLION RUPEES INVESTMENT IN KRKA PHARMA TO ACQUIRE 83.3 MILLION EQUITY SHARES IN KRKA PHARMA KRKA D.D. TO INVEST 867 MILLION RUPEES IN KRKA PHARMA Source text: ID:nNSE2b3B2q Further company coverage: LAUL.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Laurus Labs
See all newsIndia's Laurus Labs hits record high as Q2 profit more than doubles
Brief: Laurus Labs Declares Dividend Of 1 Rupee Per Share
Brief: Laurus Labs Invests 1.08 Billion Rupees Into KRKA Pharma Via Rights Issue
Brief: Laurus Labs Invests 120.96 Million Rupees In Kurnool Renewables Via Rights Issue
Four Indian stocks to be added, three removed from key global index in MSCI's August rejig